NEUROCRINE BIOSCIENCES INC Earnings Per Share Diluted

Quick Answer

NEUROCRINE BIOSCIENCES INC reported Earnings Per Share Diluted of $4.67 per share for the year ending 2025.

  • NEUROCRINE BIOSCIENCES INC showed an increase of +41.9% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from NEUROCRINE BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on February 11, 2026.
  • XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2010: $0.09 (loss) per share | Q3 2010: $0.06 per share | Q1 2011: $0.05 per share | Q2 2011: $0.04 per share | Q3 2011: $0.56 per share | Q4 2011: $0.02 per share | Q1 2012: $0.01 (loss) per share | Q2 2012: $0.01 (loss) per share | Q3 2012: $0.05 (loss) per share | Q4 2012: $0.14 per share | Q1 2013: $0.18 (loss) per share | Q2 2013: $0.18 (loss) per share | Q3 2013: $0.17 (loss) per share | Q4 2013: $0.16 (loss) per share | Q1 2017: $0.90 (loss) per share | Q2 2017: $0.68 (loss) per share | Q3 2017: $0.13 (loss) per share | Q4 2017: $0.07 per share | Q1 2018: $0.47 (loss) per share | Q2 2018: $0.07 (loss) per share | Q3 2018: $0.52 per share | Q4 2018: $0.19 per share | Q1 2019: $1.12 (loss) per share | Q2 2019: $0.54 per share | Q3 2019: $0.56 per share | Q4 2019: $0.35 per share | Q1 2020: $0.39 per share | Q2 2020: $0.81 per share | Q3 2020: $0.62 (loss) per share | Q4 2020: $3.58 per share | Q1 2021: $0.33 per share | Q2 2021: $0.43 per share | Q3 2021: $0.23 per share | Q1 2022: $0.14 per share | Q2 2022: $0.18 (loss) per share | Q3 2022: $0.69 per share | Q1 2023: $0.79 (loss) per share | Q2 2023: $0.95 per share | Q3 2023: $0.82 per share | Q1 2024: $0.42 per share | Q2 2024: $0.63 per share | Q3 2024: $1.24 per share | Q1 2025: $0.08 per share | Q2 2025: $1.06 per share | Q3 2025: $2.04 per share.
  • Over the full 17 years of available data (2009 to 2025), NEUROCRINE BIOSCIENCES INC's Earnings Per Share Diluted has grown by 459.2%.
  • Historical annual values: Fiscal year 2025: $4.67 per share | Fiscal year 2024: $3.29 per share | Fiscal year 2023: $2.47 per share | Fiscal year 2022: $1.56 per share | Fiscal year 2021: $0.92 per share | Fiscal year 2020: $4.16 per share | Fiscal year 2019: $0.39 per share | Fiscal year 2018: $0.22 per share | Fiscal year 2017: $1.62 (loss) per share | Fiscal year 2016: $1.63 (loss) per share | Fiscal year 2015: $1.05 (loss) per share | Fiscal year 2014: $0.81 (loss) per share | Fiscal year 2013: $0.69 (loss) per share | Fiscal year 2012: $0.08 per share | Fiscal year 2011: $0.67 per share | Fiscal year 2010: $0.15 (loss) per share | Fiscal year 2009: $1.30 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: